01/15/2016 | Mark Hillen
Photoreceptors – and the retina in general – are highly metabolically active. But their maxed-out mitochondria can’t give much more. And when even small metabolic imbalances arise…
12/04/2015 | Michael Schubert
5-year ATOM2 trial data confirms that 0.01% atropine is more effective at slowing myopia progression than 0.1% and 0.5% doses
12/04/2015
A specialized imaging technique has revealed two previously unknown structures of the cornea
A new matrix therapy agent may promote corneal healing after epi-off CXL, improving patient comfort and recovery times
12/04/2015 | Mark Hillen
What does analysis of the last five years of literature on endophthalmitis tell us about the priorities of the field, and the contributors to it?
12/02/2015 | Michael Schubert
Placental growth factor inhibitors might show efficacy in treating dry AMD as well as wet. Might aflibercept be repurposed?
12/02/2015 | Mark Hillen
Big data EMR mining (and some basic research) identifies a 50-year old drug that appears to protect against AMD development
A new tissue culture model of the retinal pigment epithelium may allow researchers to better understand the impacts of new interventions on the adult human retina
10/06/2015
What does analysis of the last five years of literature on femtosecond lasers tell us about the priorities of the field, and the major contributors to it?
10/05/2015
Sitting down with... Anneke den Hollander, Professor, Department of Ophthalmology, Radboud University Medical Center, Nijmegen, the Netherlands
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Redressing Representation
Living with TED: My Race from Patient to Advocate
How Dry Eye Disease Impacts Younger Patients
The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: